American Forest & Paper Association filed 1 comment on this docket between Jan 2, 2020 and Jan 2, 2020. 2 other organizations filed here. The comment window closed 2409d ago.
Please see attached AF&PA's letter to Dr. James Avery. Please disregard the comments submitted moments ago - (Comment Tracking Number: 1k3-9dz8-3tk0)These comments have the correct date - December 20 not December 19. Thank you.
EPA's Office of Research and Development is working to increase understanding about the potential human health impacts of per- and polyfluoroalkyl substances. As a part of these efforts, EPA's Integrated Risk Information System (IRIS) is developing human health assessments for the following PFAS compounds: perfluorodecanoic acid (PFDA), perfluorononanoic acid (PFNA), perfluorohexanoic acid (PFHxA), perfluorohexanesulfonate (PFHxS), and perfluorobutanoic acid (PFBA). This docket serves as a central repository for Federal Register Notices on overarching IRIS PFAS activities. Comments on individual PFAS chemicals should be provided within each chemical-specific PFAS docket.
View on regulations.gov →